Sideline Gold on Fe...
Health Care: Drugs
Regeneron Pharmaceuticals Inc. (REGN: NASDAQ)
$231.38 -11.38 | -4.69%
06/19/13 - 04:00 PM ET
Insider Trading
| Historical Data | Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | 4 Mo. Ago | 5 Mo. Ago | 6 Mo. Ago |
|---|---|---|---|---|---|---|---|
| Net Insider Transaction | -225,804 | -103,341 | -213,052 | -99,095 | -96,969 | -5,105 | -19,062 |
| Shares Bought | 599,527 | 71,627 | 577,002 | 597,002 | 581,250 | 163,115 | 198,990 |
| Shares Sold | 825,331 | 174,968 | 790,054 | 696,097 | 678,219 | 168,220 | 218,052 |
Institutional Trading
| Historical Data | Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | 4 Mo. Ago | 5 Mo. Ago | 6 Mo. Ago |
|---|---|---|---|---|---|---|---|
| Total Shares Held | 90.41M | 90.41M | 90.08M | 90.45M | 91.18M | 90.95M | 90.94M |
| Shares Bought | 22.81M | 22.80M | 24.09M | 24.24M | 24.23M | 22.99M | 22.70M |
| Shares Sold | 7.46M | 7.40M | 7.72M | 7.51M | 7.68M | 5.77M | 5.38M |
Portfolios with REGN
- Portfolio NameUser Type
- ContributorTechnical Setups for the We...
- ContributorStocks Rising On Unusual Vo...
- ContributorEarnings Short Squeeze Play...
- Contributor10 Companies That Prove Sto...
- ContributorDrugs Facing FDA Approval i...
- ContributorEarnings Short Squeeze Play...
- Contributor10 Stocks of Top-Performing...
- ContributorEarnings Short Squeeze Play...
- ContributorRelative Strength Trades fo...
- Contributor10 Stocks That Boosted Firs...
Latest REGN Headlines from TheStreet
- 3 Stocks Dragging The Drugs Industry Downward 06.19.13 | 01:06 pm
- Regeneron Pharmaceuticals Inc. (REGN): Today's Featured Health Care Laggard 06.14.13 | 05:06 pm
- 5 Drugs Stocks Dragging The Industry Down 06.10.13 | 01:06 pm
- Regeneron Pharmaceuticals Inc. Stock Buy Recommendation Reiterated (REGN) 06.10.13 | 10:06 am
- Stocks Jump on High Volatility as Investors Await Payrolls Report 06.06.13 | 05:06 pm
- Regeneron Pharmaceuticals Inc. (REGN): Today's Featured Drugs Winner 06.06.13 | 05:06 pm
- 'Mad Money' Lightning Round: Amgen's Not a Fave 06.06.13 | 06:06 am
- Cramer's 'Mad Money' Recap: Profit While You Can 06.05.13 | 08:06 pm
- Regeneron Pharmaceuticals Inc. (REGN): Today's Featured Drugs Winner 05.30.13 | 05:05 pm
- What's Your Exit Strategy? 05.30.13 | 06:05 am
Press Releases for REGN
- BioMed Realty To Develop 297,000 Square Feet In New York Fully Leased To Regeneron Pharmaceuticals - PR Newswire 04.04.13 | 09:04 am
- Regeneron Named World's #1 Biopharmaceutical Employer In Science Magazine Annual Survey - PR Newswire 09.21.12 | 12:09 pm
- Sanofi And Regeneron Launch Comprehensive Phase 3 Clinical Program With LDL Cholesterol-Lowering PCSK9 Antibody - PR Newswire 07.20.12 | 01:07 am
- Sanofi And Regeneron Announce Publication Of Positive Phase 2 Results For Lipid-Lowering PCSK9 Antibody In The Lancet - PR Newswire 05.26.12 | 11:05 am
- Sanofi And Regeneron Announce Regulatory And Clinical Update For ZALTRAP® (aflibercept) - PR Newswire 04.05.12 | 01:04 am
- Sanofi And Regeneron Report Phase 2 Data For Potential First-in-Class Lipid-Lowering PCSK9 Antibody - PR Newswire 03.26.12 | 11:03 am
- Regeneron And Bayer Announce Approval Of EYLEA® (aflibercept) Injection For The Treatment Of Wet Age-Related Macular Degeneration In Australia - PR Newswire 03.08.12 | 04:03 am
- Two Year Results Of Phase 3 Studies With EYLEA⢠(aflibercept) Injection In Wet AMD Show Sustained Improvement In Visual Acuity - PR Newswire 12.05.11 | 02:12 am
- Regeneron And Bayer Initiate Phase 3 Clinical Program For The Treatment Of Wet Age-Related Macular Degeneration In China - PR Newswire 11.28.11 | 02:11 am
- Phase 3 Trial Of ZALTRAP⢠(aflibercept) In Advanced Prostate Cancer To Continue As Planned At Recommendation Of Independent Data Monitoring Committee - PR Newswire 07.07.11 | 07:07 am
Partner Headlines for REGN
- Market Close Report: NASDAQ Composite index closes at 3,443.20 down -38.98 points - NASDAQ 06.19.13 | 08:06 pm
- Market Close Report: NASDAQ Composite index closes at 3,482.18 up 30.05 points - NASDAQ 06.18.13 | 08:06 pm
- Stocks Up Ahead Of Fed; Proto Labs Breaks Out - Investor's Business Daily 06.18.13 | 04:06 pm
- Stocks Stage Huge Comeback; Myriad Turns Tail - Investor's Business Daily 06.13.13 | 04:06 pm
- Stocks Gain, Hold Near Highs: MasterCard Finds Support - Investor's Business Daily 06.13.13 | 01:06 pm
- Short Interest Falls in Vertex, Rises in Biogen Idec (VRTX, BIIB) - Benzinga 06.12.13 | 01:06 pm
- Stocks End Near Session Lows After Comeback Attempt Fails - Investor's Business Daily 06.11.13 | 04:06 pm
- Futures Whittle Early Losses; JinkoSolar Spikes On Earnings - Investor's Business Daily 06.07.13 | 08:06 am
- Market Close Report: NASDAQ Composite index closes at 3,424.05 up 22.57 points - NASDAQ 06.06.13 | 08:06 pm
- Stocks End Up After Seesaw Ride; Regeneron Jumps 10% - Investor's Business Daily 06.06.13 | 05:06 pm
